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X-Ray Fiber Diffraction Reveals Major Structural Differences Between
Brain-Derived Prions and Recombinant Prion Protein Amyloid
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X-ray fiber diffraction was used to study the structure of brain-derived prions
and recombinant prion protein amyloid. Partially oriented, dried fibers were
prepared from brain-derived PrP 27-30 and recombinant PrP amyloid. Fiber
diffraction patterns were analyzed and used to interrogate models for the struc-
ture of the infectious prion.
Fiber diffraction patterns of recombinant PrP amyloid displayed characteristic,
meridional reflections at ~4.8 A˚ and equatorial reflections at ~10 A˚. These pat-
terns were similar to those of other amyloids and are consistent with a basic
cross-b architecture. In contrast, diffraction patterns from brain-derived PrP
27-30 displayed meridional reflections at ~9.6, ~6.4, and ~4.8 A˚, which corre-
spond to the 2nd, 3rd, and 4th order of a ~19.2-A˚ repeating unit, suggesting that
PrP 27-30 contains four b-strands in a cross-b architecture. Furthermore, PrP
27-30 lacked the typical, equatorial reflection at ~10 A˚, but instead produced
equatorial reflections characterizing the diameter of the amyloid fiber and of in-
dividual protofilaments. Therefore, PrP 27-30 seems to have a structure consis-
tent with a b-helix or b-solenoid, not unlike the model that was proposed earlier
(Govaerts et al., 2004). This interpretation was also supported by extensive
modeling, simulation of diffraction, electron microscopy, and FTIR.
In a previous study, recombinant PrP amyloid induced a transmissible prion
disease in transgenic mice overexpressing PrP, and was thus termed a "synthetic
prion" (Legname et al., 2004). Serially transmitted, synthetic prions were puri-
fied from mouse brains and analyzed by fiber diffraction. These brain-derived,
synthetic prions showed the same structural characteristics as natural prion iso-
lates and not those of its recombinant protein precursor. The relationship be-
tween structural differences and prion infectivity can be explained by several
hypotheses. It remains to be determined which one, if any, is correct.
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Mutant Huntingtin Fragments Form Oligomers in a Polyglutamine
Length-Dependent Manner
Justin Legleiter1, Paul J. Muchowski2.
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A feature of many neurodegenerative diseases is the rearrangement of a specific
protein to a non-native conformation, promoting aggregation, amyloid fibril
formation, and deposition within tissues or cellular compartments. Such dis-
eases include Alzheimer’s disease (AD), Parkinson’s disease (PD), and Hun-
tington’s disease (HD). Huntington’s disease (HD) is caused by an expansion
above 35-40 polyglutamine (polyQ) repeats in the huntingtin (htt) protein
and results in accumulation of inclusion bodies that contain fibrillar deposits
of mutant htt fragments. Intriguingly, polyQ length is directly proportional to
the propensity for htt to form fibrils and to the severity of HD, and is inversely
correlated to the age of onset. Although the structural basis for htt toxicity is
unclear, the formation, abundance and/or persistence of toxic conformers that
mediate neuronal dysfunction and degeneration in HD must also be polyQ
length-dependent. Here we used atomic force microscopy (AFM) to show
that mutant htt fragments and synthetic polyQ peptides form oligomers in
a polyQ length-dependent manner. Time-lapse AFM shows oligomers form be-
fore fibrils, are transient in nature, and are occasionally direct precursors to fi-
brils. However, the vast majority of fibrils appear to form by monomer addition
that coincides with the disappearance of oligomers. Thus, oligomers must un-
dergo a major structural transition that precedes fibril formation. These results
demonstrate that oligomer formation by a mutant htt fragment is strongly polyQ
length-dependent, consistent with a causative role for these structures in HD
pathogenesis.
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Polymorphism in Alzheimer Ab Amyloid Organization: Insight into Ab
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Yifat Miller1, Buyong Ma2, Ruth Nussinov2.
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Alzheimer disease (AD) is a progressive neurodegenerative disease associated
with accumulation of aggregated Ab1-40/Ab1-42 peptides in the brain. Ordered
aggregates can extend into b-strand enriched fibrils, regardless of their initial
native conformational states. To date, the self-assembly mechanism leading
to ordered fibril formation is not fully understood. Understanding the mecha-nisms and the range of structural features of the aggregates are of crucial im-
portance for effective drug design to reduce aggregate formation. The polymor-
phism of Ab1-42 based on ssNMR, EM, 2D hydrogen exchange and mutational
studies, was investigated using all-atom molecular dynamics simulations with
explicit solvent. Open questions relate to (1) how the monomeric peptides as-
semble into oligomers; (2) which segments of a long peptide constitute the rec-
ognition motifs and as such playing key roles in amyloid fibril formation; (3)
how the b-strands arrange relative to one another; (3) is there a favored orga-
nization between the b-sheets and if so as one would expect (4) what is it and
what are the intermolecular interactions between the layers that stabilize the fa-
vored amyloid fibril organization(s) are discussed. This project has been funded
in whole or in part with Federal funds from the NCI, NIH, under contract num-
ber HHSN261200800001E.
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Structural Determinants of Amyloid B-Protein Oligomerization
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The oligomerization of amyloid b-protein (Ab) is a seminal event in the neu-
rodegenerative process in Alzheimer’s disease (AD). Ab40 and Ab42, the
two predominant forms of Ab, display different aggregation behavior which
underlies the special pathogenetic significance of Ab42. Previous computa-
tional studies have revealed that a turn-like structure exists at the C-terminal
of Ab42 that is not observed in Ab40. We report here results of studies to define
the structure of this turn and to establish its role in Ab assembly. We used mo-
lecular dynamics to simulate the structure of the Ab C-terminus (Gly31-Val40/
Ala42) and discovered that the dihedral angles of residues 36 and 37 tend to be
locked into a region of Ramachanran space consistent with type-II b-turns.
Ab(31-42) predominantly formed a b-hairpin-like structure that was stabilized
by hydrogen bonds and hydrophobic interactions between residues 31-35 and
residues 38-42. In contrast, Ab(31-40) appeared relatively unstructured. To in-
vestigate the possible role of this peptide-specific, b-hairpin-like structure in
Ab assembly, we synthesized a number of Ab "mutants" containing amino
acid substitutions that we postulated would stabilize or destabilize the hairpin.
The stabilizing substitutions facilitated hexamer and dodecamer formation by
Ab42, abolishing formation of fibrils. Interestingly, compared to wild type
Ab42, these substituted peptides were equally toxic. When these substitutions
were incorporated into Ab40, the modified Ab40 oligomerized like Ab42, in-
stead of an "Ab40-like" distribution. In addition, the modified Ab40 was signif-
icantly more toxic than wild type Ab40. Substitutions in Ab42 that were pre-
dicted to destabilize the turn abolished hexamer and dodecamer formation
and resulted in an Ab42 oligomer size distribution similar to that of Ab40.
Our experiments appear to define the structural determinant that "makes
Ab42 Ab42." If true, this structure would be an exceptionally important ther-
apeutic target.
2366-Pos
A Solid-State NMR Study Reveals Structure and Dynamics in Copper(ii)-
Binding to Alzheimer’s Beta-Amyloid Fibrils
Yoshitaka Ishii.
Univ. Illinois at Chicago, Chicago, IL, USA.
b-amyloid (Ab) peptide associated with Alzheimer’s diseases exhibit neural
toxicity upon aggregation. One of the most widespread hypotheses on the origin
of the toxicity of Ab aggregates is the binding of Cu2þ ions to Ab fibrils and
subsequent generation of reactive oxygen species (ROS) such as H2O2 by
Cu2þ-bound Ab. Although a variety of studies have been performed on
Cu2þ-binding to Ab, the proposed binding sites or models have been controver-
sial partly because non-crystalline and insoluble nature of Ab fibrils have lim-
ited access to site-specific structure and dynamic properties on Cu2þ-bound Ab
fibrils. Here, we examine the effect of Cu2þ binding to amyloid fibrils of 40-res-
idue Ab(1-40) by UV-VIS spectroscopy and solid-state NMR (SSNMR). Spe-
cifically, we will answer the following questions (i) Is the Cu2þ binding is site
specific? (ii) If so, which sites are involved in binding? (iii) Are there any major
structural changes introduced by Cu2þ binding or oxidization due to Cu2þ?
UV-VIS spectroscopy showed that Cu2þ binds to Ab(1-40) fibrils almost com-
pletely when the ratio of Cu2þ to Ab(1-40) is less than 1. Based on the result,
we performed high-resolution SSNMR experiments on Cu2þ-bound Ab(1-40)
fibrils. First, the 13C T1 paramagnetic relaxation enhancement (PRE) due to
Cu2þ binding on Ab was measured for different residues; the PRE data high-
light possible binding sites, where the relaxation enhancements are notable.
The analysis indicates that the binding is specific, and Cu2þ most likely binds
to His-13/14 and His-6. Second, the comparison of 2D 13C/13C correlation
spectra of Ab fibrils with and without Cu2þ revealed that the secondary struc-
ture of Ab(1-40) fibrils is largely unaltered by Cu2þ binding. Third, we tested
458a Tuesday, February 23, 2010a previously proposed hypothesis that Met-35/Gly-33 can be oxidized[4] by
Cu2þ to produce ROS by SSNMR.
2367-Pos
Detecting the Aggregation of Amyloid Peptides by Spin Label EPR
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Plaques containing aggregated b-Amyloid (Ab) peptide in the brain are the
main indication of Alzheimers disease. These plaques consist of Ab fibrils.
Oligomers of Ab have been implicated as infective agents in the disease and
may also be intermediates of fibril formation. Therefore, methods to study olig-
omers on the timescale of aggregation are sought. We show that by EPR the
dynamics of spin-labeled Ab in solutions in which fibrils are formed can be de-
termined. The EPR experiments were performed on solutions of the Ab peptide
with 42 residues (1-42 Ab) containing an N-terminal cysteine, which was spin
labeled with the MTSL spin label (1-oxyl-2,2,5,5-tetramethyl-D-pyrroline-3-
methyl]methanethiosulfonate) (SL- Ab). For diamagnetic dilution, SL- Ab
was mixed with unlabeled Ab. Fibril-formation in these solutions is shown
by Congo-red binding and electron microscopy. Continuous wave, 9 GHz
EPR reveals three fractions of different spin-label mobility, a fast one attributed
to monomeric Ab, one with a mobility that corresponds to a multimer of eight
to 15 monomers, and a slow one due to larger aggregates or fibrils. The
approach, in principle, allows detection of oligomers on the timescale of
aggregation.
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Structural Characterization of Amyloids Comprised of Anchorless Prion
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Jan Stoehr, David Colby, Kurt Giles, Stanley B. Prusiner, Holger Wille.
UCSF, San Francisco, CA, USA.
Prion diseases are fatal, neurodegenerative diseases that afflict sheep, cows, and
humans. The key event in prion diseases is the conversion of the a-helical, cel-
lular isoform of the prion protein (PrPC) to an insoluble, b-sheet-rich, infectious
isoform (PrPSc). Host-encoded PrPC is anchored to the cell membrane by a gly-
cosylphosphatidyl inositol (GPI) anchor and converts to GPI-anchored PrPSc
during prion infection. Here we describe prion infection in transgenic mice
(Tg8015) that lack the signal sequence for attachment of the GPI anchor and
therefore express non-anchored, free-floating, PrPC (DGPI-PrP). The lack of
the GPI anchor leads to incomplete modification of PrP, resulting in an ungly-
cosylated molecule. Therefore, Tg8015 mice produce unglycosylated DGPI-
PrPSc upon infection with the Rocky Mountain Laboratory (RML) prion strain.
These mice did not show clinical signs of disease until >300 days post-infec-
tion (dpi), but their brains harbored DGPI-PrPSc and macroscopic amyloid de-
posits. In contrast, RML infection of wild-type (wt) mice resulted in clinical
signs of disease within 120 dpi but no macroscopic amyloid formation.
DGPI-PrPSc and wt PrPSc in the brains of Tg8015 and wt mice, respectively,
were purified by two different protocols, both involving N-terminal truncation
by proteinase K. The resulting, highly concentrated DGPI-PrP 27-30 and wt
PrP 27-30 preparations were analyzed and compared by negative-stain electron
microscopy to characterize possible differences in fibril morphology. Addi-
tional analyses were performed using Fourier transform infrared spectroscopy
and X-ray fiber diffraction to compare the structures of DGPI-PrP 27-30 amy-
loid and wt PrP 27-30 amyloid preparations. Additionally, we tested whether
DGPI-PrPSc could self-propagate in vitro by evaluating its seeding capacity
in a prion-specific amyloid seeding assay and examined its biological activity
in vivo using mouse-based bioassays.
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Oligomerization of Amphipathic Peptides in a Membrane Studied by
Coarse-Grained Molecular Dynamics Simulations
Myunggi Yi1,2, Huan-Xiang Zhou1.
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To gain insight into the aggregation and oligomerization of antimicrobial or
amyloidogenic peptides, we carried out molecular dynamics simulations of
a 26-residue amphipathic peptide at different concentrations (8, 16, and 32 cop-
ies) in a fully hydrated bilayer composed of 1600 POPC lipid molecules. With
a coarse-grained representation of the molecules, >28 microseconds of simu-
lations were accumulated for each system. Oligomers of various orders were
observed to form. The system with 32 copies of the peptide was finally com-
prised of a 4-, 7-, 8-, and 13-mer. The final compositions of the systems with16 and 8 copies of the peptide were
3-, 4-, and 9-mer for one and 3- and
5-mer for the other. Higher oligomers
were formed by addition of mono-
mers and by association of pre-
formed lower oligomers (see Figure).
Dissociation was not observed. In the
lower oligomers (up to 4-mer) only
the hydrophilic side of each copy
was buried, but in the higer oligomers
the hydrophobic sides of some copies
were also buried. These simulations
provide molecular insight into oligo-
merization of peptides inside membranes.
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Clues for the Mechanism of SEVI HIV Enhancement from Structural
Studies of the SEVI Precursor Peptide PAP248-286 in aMembrane Environ-
ment by NMR
Ravi Prakash Reddy Nanga, Jeffrey R. Brender,
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Despite the rapid progress of the AIDS pandemic, the HIV virus is a surprisingly
weak pathogen in vitro. The large difference between in vitro and in vivo infec-
tion rates suggests that cofactors absent in vitro but essential for the natural
transmission of the virus may be responsible for this discrepancy. A recently
identified peptide in human semen, PAP248-286, has emerged as a clear candi-
date for the missing cofactor as it dramatically enhances the infectivity of
HIV by up to five orders of magnitude. PAP248-286 appears to enhance HIV in-
fection by forming amyloid fibers known as SEVI, which are believed to en-
hance the attachment of the virus by bridging interactions between virion
and host-cell membranes. To understand the unique ability of SEVI to enhance
HIV infection, we have solved the atomic-level resolution structure of the SEVI
precursor PAP248-286 using NMR spectroscopy in SDS micelles. In contrast to
other toxic amyloid peptides that generally penetrate into the core of the mem-
brane, non-toxic PAP248-286 binds superficially to the surface of the micelle.
Unlike most amyloid peptides that bind to the membrane in an a-helical state,
PAP248-286 is mostly disordered when bound to the surface of the micelle. The
highly disordered nature of the SEVI peptide may explain the high ability of
SEVI to enhance HIV infection, as partially disordered amyloid fibers will
have a greater capture radius for the virus than more compact amyloid fibers.
Two regions of nascent structure match the prediction of highly amyloidogenic
sequences and may serve as nuclei for aggregation and amyloid fibril forma-
tion. NMR studies of the binding of PAP248-286 to the anti-amyloid agent
ECGC will also be presented.
2371-Pos
Formation of Toroidal Pores by Amyloid Proteins: Evidence of Lipid
Transbilayer Exchange Induced by Islet Amyloid Polypeptide
Daniel W. Youngstrom, Jeffrey R. Brender, Pieter E.S. Smith,
Kevin Hartman, Ayyalusamy Ramamoorthy.
University of Michigan, Ann Arbor, MI, USA.
Recent computer simulations have indicated that amyloid peptides disrupt
membranes by the formation of lipid-lined toroidal pores caused by excess
membrane curvature, but experimental evidence for this mechanism has
largely been lacking. A directly measurable consequence of this phenomenon
is the significantly accelerated transbilayer exchange of lipids, which is a fea-
ture of the toroidal pore mechanism but not of other mechanisms of mem-
brane disruption. Using vesicles asymmetrically labeled on the outer leaflet
by pyrene-labeled lipids, we show that toxic versions of islet amyloid poly-
peptide, an amyloid peptide implicated in the pathogenesis of type II diabetes,
induce rapid lipid flip-flop between bilayers. This manner is consistent with
antimicrobial peptides known to disrupt membranes by the toroidal pore
mechanism. We further demonstrate that a clear difference between toxic
and non-toxic versions of IAPP can be observed in their binding to bicelles
containing DMPC and the detergent DHPC, in which DHPC forms highly
curved regions resembling toroidal pores. Using this model of a pre-con-
structed toroidal pore we show that toxic rat IAPP1-19 binds in the highly
curved, pore-like DHPC enriched region while non-toxic rat IAPP1-37 binds
to the flat lamellar DMPC enriched region away from the pore. Similarly,
DSC indicates that toxic versions of the IAPP peptide strongly favor the for-
mation of negative curvature in lipid bilayers, while the non-toxic rIAPP1-37
peptide does not. Further results on other amyloid peptides (including Ab, cal-
citonin, and insulin) will also be presented as well as results from antimicro-
bial peptides.
